食用動物向け非治療用抗生物質市場：抗生物質クラス、投与経路、対象動物、抗生物質有効成分別-2025-2030年世界予測

食用動物向け非治療用抗生物質市場は2023年に47億9,000万米ドルと評価され、2024年には51億3,000万米ドルに達すると予測され、CAGR 7.18%で成長し、2030年には77億9,000万米ドルに達すると予測されています。

食用動物用の非治療用抗生物質市場の範囲と定義は、病気の治療以外の理由で抗生物質を使用することであり、主に家禽、牛、豚のような家畜の成長を促進し、飼料効率を向上させることを目的としています。このような抗生物質の必要性は、効率的な生産システムを必要とする高品質の肉、卵、酪農に対する需要の増加から生じています。これらの抗生物質は、疾病トランスミッションのリスクが高まる集約的な農業経営において、動物の健康と生産性を維持するために予防的に投与されます。しかし、規制の圧力や消費者の意識により、抗生物質の使用量を減らし、プロバイオティクスや有機農法のような代替品を好むようになり、最終用途の範囲が変化しています。

この市場の主な成長要因としては、世界の食肉消費量の増加、畜産業の進歩、獣医学的健康に関する継続的な研究などが挙げられます。新たなビジネスチャンスは、プレバイオティクスやフィトジェニックのような抗生物質の代替品の開発や、農場のバイオセキュリティ対策の強化にあります。しかし、抗生物質の使用を制限する厳しい規制、抗生物質を含まない製品に対する消費者の嗜好の高まり、抗菌剤耐性（AMR）の常に存在する脅威など、市場は大きな課題に直面しています。これらの要因から、公衆衛生や動物福祉を損なうことなく効率を高めるために革新的な研究を活用し、バランスの取れたアプローチが必要となります。

ナノテクノロジーを駆使したドラッグデリバリーシステム、精密栄養学、家畜の遺伝的進歩による自然抵抗性疾患など、イノベーションは極めて重要です。これらの分野は、より厳しい規制に対応できるだけでなく、品質や持続可能性においても優位に立てることが期待されます。企業は、こうしたソリューションを開拓するために、研究開発パートナーシップや学術機関との提携に投資すべきです。その結果、市場は持続可能な成長に向けて進化しており、消費者の期待と規制上の要求を効果的に満たすために、倫理的に生産され、効率的で、トレーサビリティのあるサプライチェーンに戦略的に焦点を当てることが求められています。こうした要因に対処することは、このダイナミックな市場環境の中で生き残るだけでなく、成功を目指す企業にとって不可欠です。

市場力学：急速に進化する食用動物向け非治療用抗生物質市場の主要市場インサイトを公開

食用動物向け非治療用抗生物質市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の動物性タンパク質需要の増加
  • 増産と疾病予防のための使用増加
• 市場抑制要因
  • 非治療用抗生物質の使用に関する政府の厳しい規制
• 市場機会
  • 水産養殖開発のための政府イニシアチブの増加
• 市場の課題
  • 植物由来の食肉製品に対する需要の増加

ポーターの5つの力：食用動物向け非治療用抗生物質市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：食用動物向け非治療用抗生物質市場における外部からの影響の把握

外部マクロ環境要因は、食用動物向け非治療用抗生物質市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析食用動物向け非治療用抗生物質市場における競合情勢の把握

食用動物向け非治療用抗生物質市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス食用動物向け非治療用抗生物質市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、食用動物向け非治療用抗生物質市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨食用動物向け非治療用抗生物質市場における成功への道筋を描く

食用動物向け非治療用抗生物質市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 動物性タンパク質の需要が世界的に増加
    • 生産性の向上と病気の予防のために利用が増加
  • 抑制要因
    • 非治療用抗生物質の使用に関する政府の厳しい規制
  • 機会
    • 養殖業の発展に向けた政府の取り組みの強化
  • 課題
    • 植物由来の肉製品の需要増加
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 食用動物向け非治療用抗生物質市場抗生物質の種類別

• 医学的に重要
  • アミノグリコシド
  • セファロスポリン
  • ランコサミド
  • マクロライド
  • ペニシリン
  • サルファ剤
  • テトラサイクリン
• 医学的に重要ではない
  • イオンフォア

第7章 食用動物向け非治療用抗生物質市場：投与経路別

• 配合飼料
• 飼料混合物
• 飼料プレミックス
• 水

第8章 食用動物向け非治療用抗生物質市場ターゲットアニマル

• アクアフィード
• 牛の飼料
• 家禽飼料
• 豚の飼料

第9章 食用動物向け非治療用抗生物質市場抗生物質有効成分

• アンピシリンとアモキシシリン
• バシトラシン
• ゲンタマイシン
• オキシテトラサイクリン
• サリノマイシン
• スルファキノキサリン
• タイロシン

第10章 南北アメリカの食用動物向け非治療用抗生物質市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の食用動物向け非治療用抗生物質市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの食用動物向け非治療用抗生物質市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Alfasan Group of Companies
• Boehringer Ingelheim GmbH
• Ceva Sante Animale
• Dechra Pharmaceuticals PLC
• Engormix
• F. Hoffmann-La Roche Ltd.
• Huvepharma
• Kremoint Pharma Pvt. Ltd.
• Lupin Limited
• Merck KGaA
• Novartis AG
• Sanofi S.A.
• Vega Group company limited
• Vetoquinol SA
• Virbac

LIST OF FIGURES

• FIGURE 1. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET RESEARCH PROCESS
• FIGURE 2. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET DYNAMICS
• TABLE 7. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CEPHALOSPORIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY LANCOSAMIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IONOPHORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COMPOUND FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MIXTURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED PREMIX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUA FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN & AMOXYCILLIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY BACITRACIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALINOMYCIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAQUINOXALINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 57. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 58. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 59. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 60. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 61. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 62. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 89. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 90. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 91. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 92. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 93. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 94. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 95. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 96. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 97. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 98. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 99. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 100. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 103. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 104. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 105. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 106. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 109. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 110. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 111. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 112. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 115. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 116. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 117. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 118. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 121. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 122. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 123. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 124. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 127. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 128. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 129. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 130. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 135. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 136. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 139. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 140. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 141. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 142. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 145. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 146. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 147. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 148. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 151. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 152. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 153. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 154. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 161. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 164. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 165. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 166. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 167. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 170. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 171. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 172. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 173. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 176. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 177. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 178. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 179. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 182. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 183. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 184. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 185. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 188. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 189. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 190. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 191. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 194. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 195. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 196. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 197. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 198. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 199. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 200. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 201. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 202. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 203. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 206. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 207. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 208. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 209. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 212. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 213. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 214. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 215. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 218. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 219. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 220. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 221. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 222. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 223. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 224. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 225. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 226. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 227. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 228. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 229. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 230. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 231. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 232. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 233. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 236. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 237. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 238. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 239. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 242. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 244. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 245. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 250. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 251. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 254. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 255. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 256. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
• TABLE 257. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
• TABLE 260. SWEDEN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 20

The Non-Therapeutic Antibiotics for Food Animals Market was valued at USD 4.79 billion in 2023, expected to reach USD 5.13 billion in 2024, and is projected to grow at a CAGR of 7.18%, to USD 7.79 billion by 2030.

The scope and definition of the non-therapeutic antibiotics market for food animals encompass the use of antibiotics for reasons beyond treating diseases, primarily to promote growth and improve feed efficiency in livestock such as poultry, cattle, and swine. The necessity of such antibiotics arises from the increasing demand for high-quality meat, eggs, and dairy, which requires efficient production systems. These antibiotics are applied prophylactically to maintain animal health and productivity in intensive farming operations where disease transmission risk is heightened. However, the end-use scope is witnessing a shift due to regulatory pressures and consumer awareness, pushing for reduced antibiotic use and favoring alternatives like probiotics and organic farming practices.

Key growth influencers in this market include the rising global meat consumption, advancements in animal husbandry practices, and ongoing research in veterinary health. Emerging opportunities lie in developing antibiotic alternatives, such as prebiotics and phytogenics, and enhancing biosecurity measures in farms. However, the market faces significant challenges, such as stringent regulations limiting antibiotic use, increasing consumer preference for antibiotic-free products, and the ever-present threat of antimicrobial resistance (AMR). These factors necessitate a balanced approach, leveraging innovative research to enhance efficiencies without compromising public health or animal welfare.

Innovation is critical, with prospects in nanotechnology-based drug delivery systems, precision nutrition, and genetic advancements in livestock to naturally resist diseases. These areas promise not only to align with stricter regulations but also provide an edge in quality and sustainability. Companies should invest in R&D partnerships and collaborations with academic institutions to pioneer these solutions. Consequently, the market is evolving towards sustainable growth, demanding a strategic focus on ethically produced, efficient, and traceable supply chains to meet consumer expectations and regulatory demands effectively. Addressing these factors is vital for businesses aiming to not only survive but also thrive in this dynamic market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Non-Therapeutic Antibiotics for Food Animals Market

The Non-Therapeutic Antibiotics for Food Animals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing demand for animal protein globally
  • Rising use for increasing production and prevention from diseases
• Market Restraints
  • Stringent government regulations on use of non-therapeutic antibiotics
• Market Opportunities
  • Increasing government initiatives for development of aquaculture
• Market Challenges
  • Increasing demand for plant-based meat products

Porter's Five Forces: A Strategic Tool for Navigating the Non-Therapeutic Antibiotics for Food Animals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Non-Therapeutic Antibiotics for Food Animals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Non-Therapeutic Antibiotics for Food Animals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Non-Therapeutic Antibiotics for Food Animals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Non-Therapeutic Antibiotics for Food Animals Market

A detailed market share analysis in the Non-Therapeutic Antibiotics for Food Animals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Non-Therapeutic Antibiotics for Food Animals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Non-Therapeutic Antibiotics for Food Animals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Non-Therapeutic Antibiotics for Food Animals Market

A strategic analysis of the Non-Therapeutic Antibiotics for Food Animals Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Non-Therapeutic Antibiotics for Food Animals Market, highlighting leading vendors and their innovative profiles. These include Alfasan Group of Companies, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Engormix, F. Hoffmann-La Roche Ltd., Huvepharma, Kremoint Pharma Pvt. Ltd., Lupin Limited, Merck KGaA, Novartis AG, Sanofi S.A., Vega Group company limited, Vetoquinol SA, and Virbac.

Market Segmentation & Coverage

This research report categorizes the Non-Therapeutic Antibiotics for Food Animals Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Antibiotic Class, market is studied across Medically Important and Non-Medically Important. The Medically Important is further studied across Aminoglycosides, Cephalosporin, Lancosamides, Macrolide, Penicillin, Sulfas, and Tetracyclines. The Non-Medically Important is further studied across Ionophores.
• Based on Route of Administration, market is studied across Compound Feed, Feed Mixtures, Feed Premix, and Water.
• Based on Target Animal, market is studied across Aqua Feed, Cattle Feed, Poultry Feed, and Swine Feed.
• Based on Antibiotic Active Ingredient, market is studied across Ampicillin & Amoxycillin, Bacitracin, Gentamicin, Oxytetracyclines, Salinomycin, Sulfaquinoxaline, and Tylosin.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand for animal protein globally
    • 5.1.1.2. Rising use for increasing production and prevention from diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent government regulations on use of non-therapeutic antibiotics
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing government initiatives for development of aquaculture
  • 5.1.4. Challenges
    • 5.1.4.1. Increasing demand for plant-based meat products
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Non-Therapeutic Antibiotics for Food Animals Market, by Antibiotic Class

• 6.1. Introduction
• 6.2. Medically Important
  • 6.2.1. Aminoglycosides
  • 6.2.2. Cephalosporin
  • 6.2.3. Lancosamides
  • 6.2.4. Macrolide
  • 6.2.5. Penicillin
  • 6.2.6. Sulfas
  • 6.2.7. Tetracyclines
• 6.3. Non-Medically Important
  • 6.3.1. Ionophores

7. Non-Therapeutic Antibiotics for Food Animals Market, by Route of Administration

• 7.1. Introduction
• 7.2. Compound Feed
• 7.3. Feed Mixtures
• 7.4. Feed Premix
• 7.5. Water

8. Non-Therapeutic Antibiotics for Food Animals Market, by Target Animal

• 8.1. Introduction
• 8.2. Aqua Feed
• 8.3. Cattle Feed
• 8.4. Poultry Feed
• 8.5. Swine Feed

9. Non-Therapeutic Antibiotics for Food Animals Market, by Antibiotic Active Ingredient

• 9.1. Introduction
• 9.2. Ampicillin & Amoxycillin
• 9.3. Bacitracin
• 9.4. Gentamicin
• 9.5. Oxytetracyclines
• 9.6. Salinomycin
• 9.7. Sulfaquinoxaline
• 9.8. Tylosin

10. Americas Non-Therapeutic Antibiotics for Food Animals Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Non-Therapeutic Antibiotics for Food Animals Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Non-Therapeutic Antibiotics for Food Animals Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alfasan Group of Companies
• 2. Boehringer Ingelheim GmbH
• 3. Ceva Sante Animale
• 4. Dechra Pharmaceuticals PLC
• 5. Engormix
• 6. F. Hoffmann-La Roche Ltd.
• 7. Huvepharma
• 8. Kremoint Pharma Pvt. Ltd.
• 9. Lupin Limited
• 10. Merck KGaA
• 11. Novartis AG
• 12. Sanofi S.A.
• 13. Vega Group company limited
• 14. Vetoquinol SA
• 15. Virbac